Ethical Longevity, NAD+ Research, and the Future of Anti-Aging
Author(s): Scott Douglas Jacobsen
Publication (Outlet/Website): The Good Men Project
Publication Date (yyyy/mm/dd): 2025/03/17
Uladzimir Sevruk is the Founder and CEO of Cata-Kor, leading advancements in NAD+ supplements and anti-aging solutions through scientific innovation, ethical longevity, and wellness. Sevruk, Founder and CEO of Cata-Kor, discusses ethical dilemmas in anti-aging interventions. He emphasizes balancing longevity benefits with societal concerns, advocating for transparency in research and equitable access to life extension technologies. Sevruk argues that longer lifespans should not exacerbate economic inequality or resource depletion, highlighting the importance of sustainability. He stresses that public involvement in these discussions ensures responsible innovation, making longevity advancements beneficial for all rather than a privileged few.
Scott Douglas Jacobsen: Experts can be split on more life. Some see these technologies as potentially revolutionary medical breakthroughs. Others are skeptical and might see them as leading to societal burden. How do you view this dichotomy?
Uladzimir Sevruk: Some people believe that life extension technologies are a discovery that will help people live longer and stay healthy. Others believe that these discoveries could create new problems, such as too many people, which will put pressure on the world economy as a whole. But people forget that everything has its pros and cons. We need to approach this issue sensibly so we can find a balance where people will live longer and it will not create problems. Also, new life extension technologies help to find cures for many diseases, which does not only prolong life but ensures quality of life.
Jacobsen: Anti-aging interventions may be inaccessible to most. What are the ethics of diverse accessibility to longevity technologies?
Sevruk: No proof-of-work for the average human of life extension techniques. But who among us doesn’t want to be healthy and live longer? And it is critical these technologies become more broadly available over time, as medicine once did. A few decades ago, surgeries and drugs were only possible for a few; now hundreds of millions of people are able to take them. The crux is that this does not turn into something dividing people into “the rich and long-lived” and “everyone else.”
Jacobsen: How can we address the ethical challenges there?
Sevruk: Life extension can only be done transparently to resolve the ethical questions around it. Companies developing these technologies need to be transparent about how they work, what risks are involved, and what benefits they provide. It shouldn’t only be scientists and business leaders who are involved in the conversation, but regular people too, to ensure decisions are made for the benefit of everyone and not just a few.
Jacobsen: Will longer lives put increased pressure on natural resources?
Sevruk: Naturally, the longer a person lives, the more food, water, housing, and energy all of humanity will need. But we can solve all of these problems if we invest in recycling and renewable energy. We have faced population growth before, this is nothing new for humanity, and we have always managed to find solutions. Technology does not stand still and is looking for a solution. The day we stop caring about the earth is our last day. And one of the ways to live longer, to live better, to live well, not just longer, is for society to be better, and that means simply caring about the environment.
Jacobsen: With Cata-Kor, how do companies ensure scientific integrity while navigating the ethical dilemmas in ambiguous emerging trends or breakthroughs in anti-aging research?
Sevruk: Companies that work on life extension must be completely transparent. Research must inspire confidence, be transparent to people, show how the methods work, open the research to the public, and pay attention to experts. This is what we at Cata-Kor believe in and uphold from our side, to provide you with the transparency and ethical accountability.
Jacobsen: Thank you for the opportunity and your time, Uladzimir.
Last updated May 3, 2025. These terms govern all In Sight Publishing content—past, present, and future—and supersede any prior notices. In Sight Publishing by Scott Douglas Jacobsen is licensed under a Creative Commons BY‑NC‑ND 4.0; © In Sight Publishing by Scott Douglas Jacobsen 2012–Present. All trademarks, performances, databases & branding are owned by their rights holders; no use without permission. Unauthorized copying, modification, framing or public communication is prohibited. External links are not endorsed. Cookies & tracking require consent, and data processing complies with PIPEDA & GDPR; no data from children < 13 (COPPA). Content meets WCAG 2.1 AA under the Accessible Canada Act & is preserved in open archival formats with backups. Excerpts & links require full credit & hyperlink; limited quoting under fair-dealing & fair-use. All content is informational; no liability for errors or omissions: Feedback welcome, and verified errors corrected promptly. For permissions or DMCA notices, email: scott.jacobsen2025@gmail.com. Site use is governed by BC laws; content is “as‑is,” liability limited, users indemnify us; moral, performers’ & database sui generis rights reserved.
In-Sight Publishing 